MSFP
KNSA icon

Mark Sheptoff Financial Planning’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Mark Sheptoff Financial Planning’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Sell
16,000
-500
-3% -$25.9K 0.54% 35
2026
Q1 		$936K Buy
16,500
+150
+0.9% +$6.64K 0.5% 38
2025
Q4 		$674K Buy
16,350
+250
+2% +$10K 0.32% 50
2025
Q3 		$625K Buy
+16,100
New +$523K 0.3% 49

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Mark Sheptoff Financial Planning's KNSA Position: Q2 2026 in Review

Mark Sheptoff Financial Planning reduced its Kiniksa Pharmaceuticals (KNSA) stake by 3% in Q2 2026, selling an estimated $25.9K and leaving 16,000 shares worth $1.02M. The position accounts for 0.54% of the portfolio, ranked #35.

Mark Sheptoff Financial Planning first reported a position in KNSA in Q3 2025 and has held it in 4 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Mark Sheptoff Financial Planning held 16,000 shares of Kiniksa Pharmaceuticals worth $1.02M as of Q2 2026.
  • Mark Sheptoff Financial Planning sold 500 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $25.9K.
  • Kiniksa Pharmaceuticals made up 0.54% of Mark Sheptoff Financial Planning's portfolio in Q2 2026, its #35 holding.
  • Mark Sheptoff Financial Planning first reported a position in Kiniksa Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Mark Sheptoff Financial Planning's 13F filing for Q2 2026, filed 13 Aug 2026.